Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Rapp currently holds 1,071,172 shares of Immunome Inc. (IMNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Rapp has been a net buyer of IMNM stock. They have purchased $5.8M and sold $0 worth of shares.
Michael Rapp's most recent insider trade was on Oct 2, 2023, when they sold 253,806 shares at $5.91 per share.
Michael Rapp serves as Executive at Immunome Inc. (IMNM). They have executed 31 insider transactions totaling $5.8M over their tenure at the company.
Michael Rapp holds the position of Executive at Immunome Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Michael Rapp has shown a buying trading pattern, with $5.8M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Rapp was on Oct 2, 2023, when they purchased $1.5M worth of IMNM shares. This transaction involved 253,806 shares at $5.91 per share.
Michael Rapp currently owns 1,071,172 shares of Immunome Inc. (IMNM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Rapp's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Rapp has 31 Form 4 filings on record as an insider at Immunome Inc..
Set alerts for Michael Rapp and 40,000+ other insiders.